Radnet Stock Price, News & Analysis

RadNet, Inc. (NASDAQ: RDNT), a leading provider of outpatient diagnostic imaging services, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. Mark Stolper, Executive Vice President and CFO, will present on Thursday, September 5th, 2024, at 11:30 a.m. Eastern Time at the New York Marriott Marquis.

The presentation will be accessible via simultaneous and archived webcasts, providing investors and interested parties an opportunity to gain insights into RadNet's operations and strategy. This event highlights RadNet's commitment to engaging with the investment community and showcasing its position in the healthcare imaging sector.

RadNet (NASDAQ: RDNT) reported strong Q2 2024 financial results, with record quarterly revenue of $459.7 million, up 13.9% year-over-year, and Adjusted EBITDA of $72.3 million, a 19.7% increase. The Digital Health segment saw significant growth, with revenue up 36.4% to $15.8 million, driven by a 136.6% increase in AI revenue. Same-center procedural volumes increased 6.1% compared to Q2 2023. RadNet revised its 2024 guidance upwards, increasing ranges for Revenue, Adjusted EBITDA, and Free Cash Flow. The company completed a successful refinancing, reducing borrowing costs and strengthening its balance sheet with a cash balance of $741.7 million and a Net Debt to Adjusted EBITDA ratio of 1.1.

RadNet, Inc. (NASDAQ: RDNT), a leading provider of high-quality, cost-effective diagnostic imaging services, has announced its upcoming second quarter 2024 financial results conference call. The call is scheduled for Thursday, August 8, 2024, at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Investors can participate by dialing 844-826-3035 (US) or 412-317-5195 (International). A simultaneous and archived webcast will be available at the provided link. An archived replay can be accessed using the passcode 10191154.

Maryland has enacted new laws to expand access to breast and lung cancer screenings, supported by RadNet. Three bills—HB 1259, HB 0934, and HB 1293—focus on affordability, quality, and education. HB 1259 prohibits copays, coinsurance, and deductibles for certain breast and lung cancer diagnostic imaging, including image-guided breast biopsy and follow-up lung diagnostics. HB 0934 tightens qualifications for x-ray operators, ensuring they meet specific training and continuing education requirements. HB 1293 mandates a three-year public education campaign on cancer prevention, targeting disproportionately affected communities. These laws will take effect in 2025.

RadNet (NASDAQ: RDNT) announced that its Executive Vice President and Chief Financial Officer, Mark Stolper, will present at the Sidoti & Company 2024 Small Cap Conference on June 12th at 12:15 p.m. Eastern Time. The event will be available via simultaneous and archived webcasts.

RadNet is a national leader in providing diagnostic imaging services through a network of outpatient imaging centers.

RadNet (NASDAQ: RDNT) will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024, at 8:40 a.m. ET. Mark Stolper, Executive Vice President and CFO, will represent the company. The conference will be held in Miami, FL, and both live and archived webcasts of the presentation will be accessible via provided URLs and on RadNet's website under 'News and Press Releases'.

RadNet, a leading provider of diagnostic imaging services, announced that its President and CEO, Dr. Howard Berger, will present at the Jefferies 2024 Global Healthcare Conference.

Taking place on June 5, 2024, in New York, at 11:30 a.m. ET, the presentation will be available via webcast at the provided links.

RadNet, Inc. will present at the Bank of America Securities 2024 Health Care Conference on May 14th, 2024. Mark Stolper, Executive Vice President and CFO, will be presenting at 3:00 p.m. Pacific Time in Las Vegas, NV. RadNet is a national leader in diagnostic imaging services with 375 outpatient imaging centers across multiple states. The company also offers radiology IT solutions, AI technology, and teleradiology services.

RadNet, Inc. reported record first quarter revenue of $431.7 million in 2024, up 10.5% from 2023. Revenue from the Digital Health segment increased by 32.3%. Adjusted EBITDA was $58.5 million, up 21.4% compared to 2023. Adjusted Earnings Per Share was $0.07, compared to a loss of $(0.22) in 2023. The company revised its 2024 guidance ranges for Revenue, Adjusted EBITDA, and Free Cash Flow upwards.